For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| MC-CBT | Self Administered Cognitive Behavior Therapy Self Administered Cognitive Behavior Therapy: This 4 session treatment is aimed at controlling symptoms by changing specific behaviors found to aggravate IBS | 0 | None | 0 | 145 | 0 | 145 | View |
| Standard-CBT | Therapist Administered Cognitive Behavior Therapy Therapist Administered Cognitive Behavior Therapy: This 10 session treatment is aimed at controlling symptoms by changing specific behaviors found to aggravate IBS | 0 | None | 0 | 146 | 0 | 146 | View |
| Education/Support | Behavioral Patient Education/Counseling Behavioral Education and Supportive Therapy: This 4 session treatment aims at controlling symptoms through support and the provision of information about IBS symptoms, how it is diagnosed, its causes, and treatment options and a collaborative, relationship between the patient and doctor | 0 | None | 1 | 145 | 0 | 145 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Attempted suicide | NON_SYSTEMATIC_ASSESSMENT | Social circumstances | None | View |